The present disclosure pertains to a system and method for automatically detecting rapid eye movement (REM) sleep and delivering sensory stimulation to prolong REM duration, without disturbing sleep. The sensory stimulation may be auditory or other stimulation. The system and method ensure timely delivery of the stimulation and automatically adjust the amount, intensity, and/or timing of stimulation as necessary. REM sleep is detected based on brain activity, cardiac activity and/or other information. REM sleep may be detected and/or predicted by a trained neural network. The amount, timing, and/or intensity of the sensory stimulation may be determined and/or modulated to enhance REM sleep in a subject based on one or more values of one or more intermediate layers of the neural network and one or more brain activity and/or cardiac activity parameters.

The present disclosure pertains to a system and method for automatically detecting rapid eye movement (REM) sleep and delivering sensory stimulation to prolong REM duration, without disturbing sleep. The sensory stimulation may be auditory or other stimulation. The system and method ensure timely delivery of the stimulation and automatically adjust the amount, intensity, and/or timing of stimulation as necessary. REM sleep is detected based on brain activity, cardiac activity and/or other information. REM sleep may be detected and/or predicted by a trained neural network. The amount, timing, and/or intensity of the sensory stimulation may be determined and/or modulated to enhance REM sleep in a subject based on one or more values of one or more intermediate layers of the neural network and one or more brain activity and/or cardiac activity parameters.

The invention concerns a blood testing device for the direct connection to a throughflow unit for blood, in particular a throughflow unit of an extracorporeal blood circuit, and for the recording of blood parameters of the blood flowing through the throughflow unit. The blood testing device can be operated without cables.

The disclosure provides systems and methods for neuromodulation using a housing that at least partially contains a stimulator assembly, wherein the stimulator assembly is configured to generate vibration by mechanical oscillation and/or using a sound wave; and wherein the vibration generated by the stimulator assembly is configured to therapeutically treat the subject by stimulating one or more nerves when the housing is placed in proximity to or on a skin surface of a subject.

The disclosure provides systems and methods for neuromodulation using a housing that at least partially contains a stimulator assembly, wherein the stimulator assembly is configured to generate vibration by mechanical oscillation and/or using a sound wave; and wherein the vibration generated by the stimulator assembly is configured to therapeutically treat the subject by stimulating one or more nerves when the housing is placed in proximity to or on a skin surface of a subject.

A robot-connected IoT-based sleep-caring system includes a sleep-caring robot and an IoT system. The sleep-caring robot includes environment monitoring, physiology monitoring, sleep monitoring, sound, lighting and electricity control, a smart storage compartment, central data processing, and machine arms. The IoT system senses and executes instructions from the sleep-caring robot, thereby catering to bedroom activities of the user.

A robot-connected IoT-based sleep-caring system includes a sleep-caring robot and an IoT system. The sleep-caring robot includes environment monitoring, physiology monitoring, sleep monitoring, sound, lighting and electricity control, a smart storage compartment, central data processing, and machine arms. The IoT system senses and executes instructions from the sleep-caring robot, thereby catering to bedroom activities of the user.

The present disclosure provides an apparatus including a first tubular housing including a first exit port and a second tubular housing including a second exit port. The apparatus also includes a third tubular housing coupled to at least one of the first tubular housing and the second tubular housing such that each of the first tubular housing, the second tubular housing, and the third tubular housing are fixed with respect to one another. The apparatus also includes a first catheter including a first plurality of outlets and is configured to be positioned at least partially within the first tubular housing. The apparatus also includes a second catheter including a second plurality of outlets and is configured to be positioned at least partially within of the second tubular housing. The apparatus also includes a pressure transducer line positioned in the third tubular housing and a pressure transducer coupled to the pressure transducer line.

The present invention is generally related to methods and systems for preventing onset or worsening of RHF in patients with implanted ventricular assist devices. More particularly, the present invention relates to identifying patients at risk for RHF following implantation of a ventricular assist device based on pulmonary artery pressure measurement and/or trends and adjusting a pump operating parameter to prevent or reduce the onset or worsening of RHF in such patients, improve patient outcomes, or reduce mortality risks associated with VAD implantation. In particular, a pump operating parameter may be adjusted to reduce or minimize particularly high pressure loads on a patient’s heart or amount of time the patient is exposed to such high pressure loads following implantation.

A method of treating a human subject which is effected by inhalation of gaseous nitric oxide, the method comprising a first treatment period comprising administering gNO by inhalation over a period of about at least 5 days, wherein the first treatment period is followed by a second treatment period comprising administering gNO by inhalation over a period of at least 3 months. The method can be utilized for treating a human subject suffering from, or prone to suffer from, a disease or disorder that is manifested in the respiratory tract, or from a disease or disorder that can be treated via the respiratory tract.